Patel Kinnari

See Remarks | Chief Operating Officer

1 company

Strong

Trades Analyzed

12M Win Rate

62.5%

Avg 3M Return

+16.4%

Avg 12M Return

+37.1%

Patel Kinnari is a See Remarks at ROCKET PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 1 buy and 9 sells.

Estimated insider holdings value: $1.6M based on current market prices.

Holdings by Company

RCKTMay 20, 2025

Current Shares441.9K

Value$1.61M

Net Activity-19,860

Bought: 27.8KSold: 47.6K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 20, 2025	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	767	$6.45	$4,944.08	-0.2%	-55.8%	-
May 16, 2025	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	1,409	$6.53	$9,197.95	-0.3%	-53.4%	-
Apr 9, 2025	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Buy	21,099	$4.70	$99,165.30	+371.8%	-45.2%	-33.3%
Feb 21, 2025	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	6,078	$10.58	$64,305.24	-1.4%	-37.3%	-63.9%
Nov 21, 2024	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	4,588	$13.05	$59,891.75	-1.2%	-14.6%	-77.1%
Aug 16, 2024	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	3,989	$18.50	$73,812.46	-1.0%	-21.9%	-83.9%
May 16, 2024	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sale+OE	4,046	$23.35	$94,474.10	-1.0%	-22.0%	-72.2%
Feb 16, 2024	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	7,132	$29.84	$212,804.62	-2.9%	-22.0%	-65.1%
Aug 17, 2023	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	1,534	$15.47	$23,732.51	-0.7%	+42.5%	+23.7%
May 17, 2023	RCKT Rocket Pharmaceuticals, Inc.	See Remarks	Sell	1,330	$21.38	$28,428.75	-0.6%	-24.7%	+8.5%